News | August 07, 2024
Bayer Group posts 2Q 2024 sales up 3.1% at € 11.14 billion
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
The drugmaker's net profit slipped 26 per cent on-year to Rs 143.8 crore
Shivani Satish Wagh takes on the role of Joint Managing Director
EBITDA at Rs. 250 crore, up 47% YoY, with 35% EBITDA margin
Q1 FY25 revenues up 20% YoY to Rs. 1,002 crore
Q1 Consolidated operating profit Up 8.3%; revenue grows 7% to Rs 3,349 crore
Sun Pharmaceutical Industries has reported total income of Rs. 13,185.30 crores during the period ended June 30, 2024
This product will be manufactured at Lupin’s Nagpur facility in India and will be supplied to low and middle-income countries
The revenue for the Q1FY25 came in at Rs 1,085.7 crore, up 16.6 per cent YoY
Granules India has reported total income of Rs. 1181.92 crores during the period ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
